Phase II study of chemoradiotherapy for advanced squamous cell carcinoma of the thoracic esophagus: nine Japanese institutions trial.

Ishida, K; Iizuka, T; Ando, N; Ide, H

Ishida, K; Iizuka, T; Ando, N; Ide, H.

Affiliation

Ishida K; Department of Surgery 1, School of Medicine, Iwate Medical University, Morioka.

Jpn J Clin Oncol ; 26(5): 310-5, 1996 Oct.

Article in En | MEDLINE | ID: mdl-8895670

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Carcinoma, Squamous Cell/drug therapy; Carcinoma, Squamous Cell/radiotherapy; Esophageal Neoplasms/drug therapy; Esophageal Neoplasms/radiotherapy; Adult; Aged; Antimetabolites, Antineoplastic/administration & dosage; Antimetabolites, Antineoplastic/adverse effects; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Carcinoma, Squamous Cell/mortality; Cisplatin/administration & dosage; Cisplatin/adverse effects; Esophageal Neoplasms/mortality; Female; Fluorouracil/administration & dosage; Fluorouracil/adverse effects; Humans; Male; Middle Aged; Quality of Life; Radiotherapy, Adjuvant; Recurrence

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Esophageal Neoplasms / Carcinoma, Squamous Cell / Antineoplastic Combined Chemotherapy Protocols Language: En Journal: Jpn J Clin Oncol Year: 1996 Type: Article

Search on Google

Add to My VHL

XML

PubMed Links